tiprankstipranks
Trending News
More News >

Turnstone Biologics downgraded to Underperform from Neutral at BofA

BofA downgraded Turnstone Biologics (TSBX) to Underperform from Neutral with a 40c price target

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1